C3.ai stock rating reiterated at Underperform by Wolfe Research

C3.ai's preliminary Q1 FY26 results significantly missed guidance, prompting Wolfe Research to reiterate an Underperform rating with a $15 price target and DA Davidson to downgrade to Underperform with a $13 target, citing weak performance and the company's failure to reiterate guidance. This financial underperformance, coupled with CEO Thomas Siebel's announced departure and an ongoing search for a successor, signals significant operational challenges for the company despite recent strategic partnerships with Huntington Ingalls and Univation Technologies.

Analysis

C3.ai (AI) is facing significant operational and financial headwinds, underscored by preliminary Q1 FY26 results that fell substantially short of previous guidance. This miss has triggered sharp negative reactions from the analyst community, with Wolfe Research reiterating an 'Underperform' rating and a $15.00 price target, and DA Davidson downgrading the stock to 'Underperform' with a $13.00 price target—both representing material downside from its current $22.13 price. Compounding these issues is a critical leadership transition as CEO Thomas M. Siebel steps down, creating uncertainty. The company's failure to reiterate its guidance in its 8-K filing is a key risk factor, suggesting a potential downward revision or full withdrawal of its FY26 revenue forecast. This bearish outlook is supported by InvestingPro data indicating 'WEAK' financial health, a stock decline of over 30% in the past six months, and a consensus that profitability is not expected this year. While new strategic partnerships with major industrial players like Huntington Ingalls (HII) and Univation Technologies demonstrate progress in applying its technology in the defense and petrochemical sectors, these long-term initiatives are currently overshadowed by the immediate execution challenges and financial underperformance.

Key Decisions for Investors

• Given the significant earnings miss and dual analyst downgrades with price targets well below the current market price, investors should be aware of the heightened near-term downside risk and execution uncertainty.
• It is critical to monitor upcoming catalysts, including the official Q1 earnings report, any formal update or withdrawal of FY26 guidance, and announcements regarding the CEO succession, as these will be pivotal for the stock's direction.
• Consider the disconnect between the company's immediate operational challenges and the long-term potential of its strategic partnerships, which may appeal to patient, high-risk tolerance investors but presents significant short-term volatility.